Yang Shen

5.6k total citations · 1 hit paper
115 papers, 3.3k citations indexed

About

Yang Shen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yang Shen has authored 115 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 26 papers in Hematology and 21 papers in Oncology. Recurrent topics in Yang Shen's work include Acute Myeloid Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Yang Shen is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Yang Shen collaborates with scholars based in China, United States and United Kingdom. Yang Shen's co-authors include Sai‐Juan Chen, Yongmei Zhu, Jingyi Shi, Chen Zhu, Zhaohui Gu, Zhixiang Shen, Jie Xu, Chun‐Ming Pan, Jian‐Qing Mi and Junmin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Yang Shen

102 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

2011 587 citations Yang Shen, Sai‐Juan Chen et al. profile →

Peers

Countries citing papers authored by Yang Shen

Since Specialization

Citations

This map shows the geographic impact of Yang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Shen more than expected).

Fields of papers citing papers by Yang Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Shen. The network helps show where Yang Shen may publish in the future.

Co-authorship network of co-authors of Yang Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Shen. A scholar is included among the top collaborators of Yang Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Shen. Yang Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Associations of estimated plasma volume status with 30-day mortality and 1-year mortality in patients with intracerebral hemorrhage: a study of the MIMIC-IV database and the hospital information system 2025 ·Frontiers in Neurology ·Yang Shen, Yingjie Shen, (unknown), (unknown), (unknown), Yuliang Feng, Yang Yang, Xiangtong Zhang, Hongsheng Liang	0
2	From Brain to Insomnia: Can Neurotrophic Factors Unlock the Sleep Puzzle After Stroke? [Letter] 2025 ·Nature and Science of Sleep ·Yang Shen, Hongguang Pan, (unknown)	1
3	Elevated atherogenic index of plasma is associated with increased cardiorenal syndrome prevalence: a cross-sectional study 2025 ·Renal Failure ·(unknown), Jianping Hu, (unknown), Maolin Yuan, Yan Zheng, Xin Liu, Yang Shen	1
4	OA05.03 Ablation to Oligo-Residual Sites Plus ICIs Improved Survival of Patients with Advanced NSCLC: Preliminary Results of a Prospective Phase II Trial 2024 ·Journal of Thoracic Oncology ·Yang Shen, Bing Chen, Jie Yu, Xi Liu, (unknown), Feng Wu, Ang Li, Guodong Gao, (unknown), (unknown)	0
5	The Level and Outcomes of Emotional Labor in Nurses: A Scoping Review 2024 ·Journal of Nursing Management ·(unknown), Meng Zhang, (unknown), (unknown), Yang Shen, (unknown), (unknown)	6
6	Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo 2024 ·Journal of Nanobiotechnology ·Yuefeng Zhang, (unknown), Wei Song, Xiaoqin He, Yi Qin, (unknown), X. Mao, Wei Wang, Yangtao Xu, Yang Shen, Peng Ma, Kaihuan Yu	0
7	A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene 2023 ·Frontiers in Pediatrics ·(unknown), (unknown), Yang Shen, Fang Xu, Fei Xu, Hui Huang, (unknown)	1
8	Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial 2023 ·Frontiers in Pediatrics ·(unknown), (unknown), Sisi Wei, (unknown), Yang Shen, Yanting Wang, (unknown), Mazhong Zhang, (unknown)	3
9	Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer 2023 ·Cancer Control ·Bo Ding, Wenjing Yan, Siyuan Shen, Dan Meng, Chen Xue, Shizhi Wang, Yang Shen	3
10	ED ₅₀ and ED ₉₅ of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose‐finding study using up‐and‐down sequential allocation method 2022 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Yang Shen, Yanyan Yang, (unknown), Yanting Wang, (unknown), Jijian Zheng, (unknown)	28
11	Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia 2021 ·Clinical Cancer Research ·(unknown), Q. L. Niu, Yang Shen, Hai Fang, (unknown), Bowen Cui, Li Chen, Hongming Zhu, Sujiang Zhang, Yu Chen, Lu Jiang, Shengyue Wang, Junmin Li, Bingshun Wang, Bing Chen, Zhu Chen, Sai‐Juan Chen	15
12	The safety of morphine in patients with acute heart failure: A systematic review and meta‐analysis 2021 ·Clinical Cardiology ·Dandan Zhang, Lai Wei, Xiao Liu, Yang Shen, Kui Hong	12
13	Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 2021 ·European Journal of Pharmacology ·Tingting Lu, (unknown), Fengming Zou, Xixiang Li, Aoli Wang, Wenliang Wang, Huamin Liang, Qingwang Liu, (unknown), Chen Hu, Cheng Chen, Zhenquan Hu, Wenchao Wang, Lili Li, Jian Ge, Yang Shen, Tao Ren, Jing Liu, Ruixiang Xia, Qingsong Liu	8
14	Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1 2019 ·Cell Death and Disease ·Yongsheng Jiang, Ruizhe He, Yuhong Jiang, Dejun Liu, Ling‐Ye Tao, Minwei Yang, Chaoyi Lin, Yang Shen, Xueliang Fu, Jian‐Yu Yang, Jiao Li, Yan‐Miao Huo, Rong Hua, Wei Liu, Junfeng Zhang, Baiyong Shen, Zhigang Zhang, Yongwei Sun	59
15	DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma 2019 ·Journal of Immunology Research ·Jian‐Yu Yang, Yongsheng Jiang, Ruizhe He, Wei Liu, Minwei Yang, Ling‐Ye Tao, Xueliang Fu, Yang Shen, Jiao Li, Dejun Liu, Yan‐Miao Huo, Junfeng Zhang, Rong Hua, Zhigang Zhang, Yongwei Sun	9
16	Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies 2016 ·International Journal of Cardiology ·Wengen Zhu, Ping Yuan, Yang Shen, Rong Wan, (unknown)	71
17	A case of advanced lung cancer with malignant pericardial effusion treated by intrapericardial Cinobufacini injection instillation 2014 ·BioScience Trends ·Tao Sun, Yuhua Zhang, Yang Shen, Kaiwen Hu, (unknown)	11
18	Combined therapy of percutaneous cryoablation and traditional Chinese medicine can be a promising strategy for elderly or advanced lung cancer patients based on a retrospective clinical study 2014 ·Cryobiology ·(unknown), Quanwang Li, Min Jiang, (unknown), (unknown), (unknown), Yang Shen, Guijian Liu, Kaiwen Hu	13
19	Effects of dl-3-butylphthalide soft capsules on treatment of acute ischemlC stroke: multi-center, randomized, double-blind, double-dummy and aspirin-control study 2008 ·(unknown), Shun-wei Li, Weiwei Zhang, (unknown), He Li, (unknown), Yang Shen, Yongjun Wang, Xuguang Gao, Jianping Jia, Jinsheng Zeng, En Xu, (unknown), Jia He	2
20	Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report 2002 ·Journal of Cancer Research and Clinical Oncology ·Wu H, Ruoh‐Fang Yen, Yang Shen, (unknown), Cheng‐Chieh Lin, Lee C	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact